New Onset Type 1 Diabetes: Role of Exenatide

NCT01269034 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Exenatide
DRUG: Rapid and long acting insulin
DRUG: long acting insulin + rapid acting + 1.25 mcg Exenatide

Sponsor

Albert Einstein College of Medicine

Collaborators

[object Object]